Venous thromboembolism in hospitalized patients--are we doing enough to prevent it? Commentary to the ENDORSE trial.
Anderson
Frederick A
FA
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006761:Hospitals / Q000706:statistics & numerical data; D006801:Humans; D007297:Inpatients / Q000706:statistics & numerical data*; D008297:Male; D008485:Medical Audit / Q000706:statistics & numerical data*; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010346:Patient Care Management / Q000706:statistics & numerical data; D011044:Poland / Q000453:epidemiology; D011183:Postoperative Complications / Q000517:prevention & control; D018570:Risk Assessment; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*
D000925:Anticoagulants; D005343:Fibrinolytic Agents